3 results match your criteria: "New York Roswell Park Cancer Institute[Affiliation]"
Benign Polypoid Epithelioid Schwannoma.
Dermatol Surg
May 2017
University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York Western New York Dermatology, PLLC, Williamsville, New York Roswell Park Cancer Institute, Buffalo, New York.
Treatment-related Hypertension as a Pharmacodynamic Biomarker for the Efficacy of Bevacizumab in Advanced Pancreas Cancer: A Pooled Analysis of 4 Prospective Trials of Gemcitabine-based Therapy With Bevacizumab.
Am J Clin Oncol
December 2016
*Department of Oncology, Oklahoma University, Oklahoma City, OK †Department of Internal Medicine, The Ohio State University, Columbus, OH ‡Department of Internal Medicine, University of California, San Francisco, CA §Mount Sinai School of Medicine, One Gustave Levy Place, New York ¶Roswell Park Cancer Institute, Buffalo, NY ∥1500 E Medical Center Dr, University of Michigan, Ann Arbor, MI #MD Anderson Cancer Center, Houston, TX.
Purpose: Phase III studies of bevacizumab in advanced pancreas cancer (APCA) demonstrated no improvement in outcome. No validated biomarkers for bevacizumab efficacy exist. We evaluated bevacizumab-related hypertension (B-HTN) as a biomarker in APCA patients in a pooled analysis from 4 prospective clinical trials of gemcitabine-based therapy combined with bevacizumab.
View Article and Find Full Text PDFPericardial catheter sclerosis versus surgical procedures for pericardial effusions in cancer patients.
J Cardiovasc Surg (Torino)
June 2001
Department of Thoracic Surgical Oncology, State University of New York & Roswell Park Cancer Institute, Buffalo, New York 14263, USA.
Background: Approximately 21% of patients with advanced malignancies have cardiac or pericardial involvement with tumor. Controversy exists regarding the optimal approach to the pericardial space when hemodynamic compromise due to effusions occurs.
Methods: A six-year retrospective review of 59 cancer patients with pericardial effusions.